221 related articles for article (PubMed ID: 24105052)
1. [Chemotherapy for malignant gliomas: an update].
Wakabayashi T; Natsume A; Fujii M
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1283-7. PubMed ID: 24105052
[TBL] [Abstract][Full Text] [Related]
2. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
Silber JR; Blank A; Bobola MS; Ghatan S; Kolstoe DD; Berger MS
Clin Cancer Res; 1999 Apr; 5(4):807-14. PubMed ID: 10213216
[TBL] [Abstract][Full Text] [Related]
3. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL
J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trial updates for malignant brain tumors].
Wakabayashi T
Rinsho Shinkeigaku; 2011 Nov; 51(11):853-6. PubMed ID: 22277391
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trial of MCNU for malignant brain tumors].
Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
[TBL] [Abstract][Full Text] [Related]
6. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
7. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A
BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas.
Yoshino A; Tashiro S; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Sano E; Tsumoto K
Int J Oncol; 2011 Sep; 39(3):529-42. PubMed ID: 21805051
[TBL] [Abstract][Full Text] [Related]
11. New developments in the treatment of malignant gliomas.
Soffietti R; Leoncini B; Rudà R
Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in malignant glioma--a target for antitumor therapy?
Tuettenberg J; Friedel C; Vajkoczy P
Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
[TBL] [Abstract][Full Text] [Related]
13. The role of cytotoxic drugs in the treatment of central nervous system gliomas.
Neyns B; D'haeseleer M; Rogiers A; Van de Cauter J; Chaskis C; Michotte A; Strik H
Acta Neurol Belg; 2010 Mar; 110(1):1-14. PubMed ID: 20514922
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
[TBL] [Abstract][Full Text] [Related]
15. [Anti-angiogenic therapy for malignant glioma].
Nagane M
Gan To Kagaku Ryoho; 2014 Feb; 41(2):141-7. PubMed ID: 24743191
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of high grade malignant gliomas in adults: an overview.
Brandes A; Soesan M; Fiorentino MV
Anticancer Res; 1991; 11(2):719-27. PubMed ID: 2064325
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
18. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.
Tanaka S; Kamitani H; Amin MR; Watanabe T; Oka H; Fujii K; Nagashima T; Hori T
J Neurooncol; 2000; 46(2):157-71. PubMed ID: 10894369
[TBL] [Abstract][Full Text] [Related]
19. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.
Neyns B; Sadones J; Chaskis C; De Ridder M; Keyaerts M; Veld PI; Michotte A
Acta Neurol Belg; 2005 Sep; 105(3):137-43. PubMed ID: 16255151
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for high-grade gliomas of childhood.
Pollack IF; Boyett JM; Finlay JL
Childs Nerv Syst; 1999 Oct; 15(10):529-44. PubMed ID: 10550584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
